Archive Category: HyperCycle Blueprint (Alerts)

As dictated by our HyperCycle Blueprint calendar… We have not one but two new opportunities to get ourselves positioned for today! One is a quick, 10-trading-day trade… The other is a longer-lasting one, which we’ll plan to exit in mid-November.

First, I want to extend a warm welcome to all the new faces! If you joined my presentation yesterday, you already know we have a new opportunity kicking off in Albemarle Corp. (ALB) today. Let’s dive in so we’re all on the same page and can be positioned properly…

Shares of memory and storage technology firm Sandisk Corp. (SNDK) have traded higher between August 17 and October 29 … 100% of the time. Now, here’s the truth: The sample size of that statistic is one (1). You probably already know that Mark Twain quote:

Cytokinetics (CYTK) is a pharmaceutical company that specializes in heart disease. Its lead product is aficamten (branded MYQORZO), which is a cardiac myosin inhibitor that is now approved in the U.S., Europe and China for adults with symptomatic obstructive hypertrophic cardiomyopathy.

One thing you’ll learn about a “seasonality” strategy, like ours, is that putting the odds heavily in your favor doesn’t mean any stock move is guaranteed. Sometimes the HyperCycle profit window we’re targeting shows up late, just after we’ve exited a position. We’re seeing that this week as shares of Gold Fields Ltd. (GFI) have now lived up to the expectation we had for them when we entered a bullish position on July 13.